Japanese Prescription Sleeping Pill Daily Dosage Increases 30 Percent In Four Years
This article was originally published in PharmAsia News
According to a recent report released by Japan's Ministry of Health, Labor and Welfare, the average daily dose of prescription sleeping pills per person in Japan increased 30 percent from 2005 to 2009
You may also be interested in...
Gilead clarifies position on Cipla’s sub-licensing effort for remdesivir, the investigational antiviral in the global spotlight as a potential treatment for COVID-19.
Discovered at record-breaking speed by AbCellera, Lilly says the antibody candidate could progress into Phase II trials by June.
While the COVID-19 pandemic continued to dominate EU-wide medtech decisions in May, further analysis of the one-year delay to the EU’s new regulations revealed some unexpected consequences. Meanwhile, a new flurry of documents and decisions have been produced by the European Commission.